Page 340 - Haematologica Vol. 109 - July 2024

LETTER TO THE EDITOR
Disclosures
No conflicts of interest to disclose.
Contributions
SS and AZ conceptualized, designed, and performed research. SS, SZ and AZ analyzed the data. SY and RS blindly and independently adjudicated abnormal whole blood aggregation results for all participants. SS and AZ wrote, and all other authors critically edited the manuscript.
References
1. Podda G, Femia EA, Pugliano M, Cattaneo M. Congenital defects of platelet function. Platelets. 2012;23(7):552-563.
2. Nurden AT, Freson K, Seligsohn U. Inherited platelet disorders. Haemophilia. 2012;18(Suppl 4):154-160.
3. McGarry GW. Recurrent epistaxis in children. BMJ Clin Evid. 2013;2013:0311.
4. Carpenter RF. The prevalence and distribution of bruising in babies. Arch Dis Child. 1999;80(4):363-366.
5. Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065.
6. Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831-835.
7. Zia A, Jain S, Kouides P, et al. Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort. Haematologica. 2020;105(7):1969-1976.
8. Zhou L, Schmaier AH. Platelet aggregation testing in platelet- rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol. 2005;123(2):172-183.
Funding
This work was supported by the National Institutes of Health (grant N. 1R01HL153963), the American Heart Association (grant N. 20IPA35320263), and the National Heart, Lung, and Blood Institute (grant N. R38HL150214).
Data-sharing statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
9. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280-300.
10. Bidlingmaier C, Grote V, Budde U, Olivieri M, Kurnik K. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice. J Thromb Haemost. 2012;10(7):1335-1341.
11. Adler M, Kaufmann J, Alberio L, Nagler M. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J Thromb Haemost. 2019;17(7):1104-1112.
12. Gresele P, Falcinelli E, Bury L, et al. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2021;19(5):1364-1371.
13. Gresele P, Orsini S, Noris P, et al. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC. J Thromb Haemost. 2020;18(3):732-739.
Haematologica | 109 July 2024
2354